1. Home
  2. TVRD vs RVP Comparison

TVRD vs RVP Comparison

Compare TVRD & RVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tvardi Therapeutics Inc.

TVRD

Tvardi Therapeutics Inc.

SELL

Current Price

$1.09

Market Cap

15.7M

Sector

Health Care

ML Signal

SELL

RVP

Retractable Technologies Inc.

SELL

Current Price

$0.53

Market Cap

16.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
TVRD
RVP
Founded
2017
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.7M
16.6M
IPO Year
2013
2000

Fundamental Metrics

Financial Performance
Metric
TVRD
RVP
Price
$1.09
$0.53
Analyst Decision
Buy
Analyst Count
9
0
Target Price
★ $8.88
N/A
AVG Volume (30 Days)
★ 207.0K
20.6K
Earning Date
11-13-2026
11-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 79.01
N/A
EPS
N/A
★ N/A
Revenue
$911,000.00
★ $38,266,211.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 959.30
15.78
52 Week Low
$0.77
$0.55
52 Week High
$5.69
$0.87

Technical Indicators

Market Signals
Indicator
TVRD
RVP
Relative Strength Index (RSI) 50.87 30.84
Support Level $0.85 N/A
Resistance Level $2.02 $0.59
Average True Range (ATR) 0.17 0.02
MACD 0.05 0.00
Stochastic Oscillator 41.46 46.67

Price Performance

Historical Comparison
TVRD
RVP

About TVRD Tvardi Therapeutics Inc.

Tvardi Therapeutics Inca clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting Signal Transducer and Activator of Transcription 3 (STAT3) to treat inflammatory and proliferative diseases with unmet need. Its pipeline includes two oral, small molecule STAT3 inhibitors: TTI-101 and TTI-109. TTI-101 is its first-generation direct STAT3 inhibitor, currently in Phase 1b/2 clinical development in hepatocellular carcinoma (HCC). TTI-109 is a phosphate prodrug of TTI-101 that is mechanistically identical to its parent molecule but is designed to enhance its ability to target STAT3.

About RVP Retractable Technologies Inc.

Retractable Technologies Inc is engaged in the manufacturing and marketing of safety medical products (predominantly syringes) for the healthcare industry. It has manufacturing facilities in Little Elm, Texas, and uses manufacturers in China as well. Its syringes are well-suited for administering vaccinations. The company's products are VanishPoint Syringe, VanishPoint Insulin Syringes, EasyPoint Needle, EasyPoint Blood Collection Tube with Needle, VanishPoint Blood Collection Set, and VanishPoint IV Catheter. It provides solutions such as Insulin, Immunization, Blood Collection, Allergy, General Purpose, and Infusion.

Share on Social Networks: